Regadenoson R-T Perfusion Imaging Trial

NCT00837369 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Myocardial Perfusion Abnormalities

Interventions

DRUG: Regadenoson

Sponsor

University of Nebraska

Collaborators

[object Object]
[object Object]